Abstract: The centrality of heavy-ion collisions is directly related to the created medium in these interactions. A procedure to determine the centrality of collisions with the LHCb detector is implemented for lead-lead collisions root s(NN) = 5 TeV and lead-neon fixed-target collisions at root s(NN) = 69 GeV. The energy deposits in the electromagnetic calorimeter are used to determine and define the centrality classes. The correspondence between the number of participants and the centrality for the lead-lead collisions is in good agreement with the correspondence found in other experiments, and the centrality measurements for the lead-neon collisions presented here are performed for the first time in fixed-target collisions at the LHC.

Abstract: PurposeA joint working group was created by the American Association of Physicists in Medicine (AAPM), the European Society for Radiotherapy and Oncology (ESTRO), and the Australasian Brachytherapy Group (ABG) with the charge, among others, to develop a set of well-defined test case plans and perform calculations and comparisons with model-based dose calculation algorithms (MBDCAs). Its main goal is to facilitate a smooth transition from the AAPM Task Group No. 43 (TG-43) dose calculation formalism, widely being used in clinical practice for brachytherapy, to the one proposed by Task Group No. 186 (TG-186) for MBDCAs. To do so, in this work a hypothetical, generic high-dose rate (HDR) Ir-192 shielded applicator has been designed and benchmarked. MethodsA generic HDR Ir-192 shielded applicator was designed based on three commercially available gynecological applicators as well as a virtual cubic water phantom that can be imported into any DICOM-RT compatible treatment planning system (TPS). The absorbed dose distribution around the applicator with the TG-186 Ir-192 source located at one dwell position at its center was computed using two commercial TPSs incorporating MBDCAs (Oncentra((R)) Brachy with Advanced Collapsed-cone Engine, ACE, and BrachyVision ACUROS) and state-of-the-art Monte Carlo (MC) codes, including ALGEBRA, BrachyDose, egs_brachy, Geant4, MCNP6, and Penelope2008. TPS-based volumetric dose distributions for the previously reported source centered in water and source displaced test cases, and the new source centered in applicator test case, were analyzed here using the MCNP6 dose distribution as a reference. Volumetric dose comparisons of TPS results against results for the other MC codes were also performed. Distributions of local and global dose difference ratios are reported. ResultsThe local dose differences among MC codes are comparable to the statistical uncertainties of the reference datasets for the source centered in water and source displaced test cases and for the clinically relevant part of the unshielded volume in the source centered in applicator case. Larger local differences appear in the shielded volume or at large distances. Considering clinically relevant regions, global dose differences are smaller than the local ones. The most disadvantageous case for the MBDCAs is the one including the shielded applicator. In this case, ACUROS agrees with MC within [-4.2%, +4.2%] for the majority of voxels (95%) while presenting dose differences within [-0.12%, +0.12%] of the dose at a clinically relevant reference point. For ACE, 95% of the total volume presents differences with respect to MC in the range [-1.7%, +0.4%] of the dose at the reference point. ConclusionsThe combination of the generic source and generic shielded applicator, together with the previously developed test cases and reference datasets (available in the Brachytherapy Source Registry), lay a solid foundation in supporting uniform commissioning procedures and direct comparisons among treatment planning systems for HDR Ir-192 brachytherapy.

Abstract: We present a method to minimize, or even cancel out, the nuisance parameters affecting a measurement. Our approach is general and can be applied to any experiment or observation where systematic errors are a concern e.g. are larger than statistical errors. We compare it with the Bayesian technique used to deal with nuisance parameters: marginalization, and show how the method compares and improves by avoiding biases. We illustrate the method with several examples taken from the astrophysics and cosmology world: baryonic acoustic oscillations (BAOs), cosmic clocks, Type Ia supernova (SNIa) luminosity distance, neutrino oscillations and dark matter detection. By applying the method we not only recover some known results but also find some interesting new ones. For BAO experiments we show how to combine radial and angular BAO measurements in order to completely eliminate the dependence on the sound horizon at radiation drag. In the case of exploiting SNIa as standard candles we show how the uncertainty in the luminosity distance by a second parameter modelled as a metallicity dependence can be eliminated or greatly reduced. When using cosmic clocks to measure the expansion rate of the universe, we demonstrate how a particular combination of observables nearly removes the metallicity dependence of the galaxy on determining differential ages, thus removing the agemetallicity degeneracy in stellar populations. We hope that these findings will be useful in future surveys to obtain robust constraints on the dark energy equation of state.